| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9344225 | Journal of Cataract & Refractive Surgery | 2005 | 6 Pages |
Abstract
The data show that, depending on the concentration, octreotide is able to decrease proliferative responses of LECs. Moreover, the cell proliferation induced by growth factors was potently inhibited by octreotide. Therefore, octreotide could be a potential drug after cataract surgery in prevention of growth factor-dependent proliferative disorders such as posterior capsule opacification and anterior capsule contraction in diabetic patients.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Alicja PhD, Yvonne D. MD, Gerhard K. MD, Gabriele E. MD,